TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
HSDT

Helius Medical Technologies Inc Class A

Financial Services · Asset Management

2.60$ -8.4% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow HSDT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – -4,104.8% -1,403.7% -1,775.8% -2,564.8% -1,818.3% -1,617.4% -2,123.3% -274.5%
– – – – 12.3% 12.8% 72.9% 71.6% 38.9% 25.2% 11.5% 11.3%
– – – – 1,693.5% 313.6% 382.6% 814.6% 286.4% 253.0% 485.0% 153.7%
– – – – 2,083.9% -610.4% 451.1% 824.7% 103.3% – – –
– – – – -213.0% -152.2% -153.7% 24.3% -165.9% -48.3% -1.5% 3.8%
– – – – 92.1% 18.6% 9.5% 10.3% 2.2% 4.5% 1.0% 744.2%
– – – – -92.1% -51.4% -1.4% -10.7% -1.4% -4.5% -1.0% -7,088.8%
– – – – 8,374.1% 110.5% 1,458.1% – – – – –
– – – – – – – 0.0% – – 0.0% -11.3%
– – – – 8,374.1% 110.5% 1,458.1% 4,047.1% 2,270.5% 167.2% 1,337.3% 7,466.2%
– – – – 4,188.5% -1,345.2% -321.9% 1,470.1% 450.3% -1,454.5% -787.3% 102.9%
– – – – -4,196.9% -1,422.3% -1,785.3% -2,575.1% -1,820.5% -1,621.9% -2,124.2% -1,018.7%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?